Bonyf: CEO regrets stock market performance and bets on Periocream in Italy
In a letter to shareholders published on 30 October 2026, Jean-Pierre Bogaert, founder and CEO of Bonyf, acknowledged the disappointment caused by a share price well below levels reached in the past. He said he regretted the financial impact on shareholders who may need to sell at the current valuation.
Without announcing any new decision, the executive reiterated the group's commercial priorities and reaffirmed his confidence in the company's commercial potential.
Italy leads distribution discussions for Periocream
The group, which specialises in dental products and dermatological solutions, said it promotes its brands through targeted advertising campaigns on social networks, with early results described as encouraging. The main priority nevertheless remains Periocream, which management presents as a significant growth opportunity.
As announced in a previous press release, Bonyf is negotiating distribution agreements in more than 15 countries, with Italy paving the way. In this market, a specialised dental platform partnering with the group conducted a sampling campaign among practitioners.
More than 1,300 dentists and dental hygienists requested and received a sample of Periocream. According to the Italian partner, this result reflects strong interest from professionals in the product.
Next step: turning interest into recurring orders
The executive identified the decisive next step as converting this interest into regular use of Periocream by professionals, in order to generate repeat orders and lasting sales. In his view, a successful adoption in Italy could serve as a model for expansion into other countries.
Jean-Pierre Bogaert also said that growth resulting from recurring sales has the potential to be reflected over time in the share price. In its warnings, the company stated that requests for samples do not guarantee future sales and that no assurance can be given regarding its financial performance or the evolution of its share price.